Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InspireMD, Inc.NSPR · Entity 7318 | EVP, Chief Commercial Officer | October 24, 2016 | October 26, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InspireMD, Inc.
Report date October 24, 2016 · Filed October 26, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options to purchase common stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.86 · Expires 2026-10-24 | Direct | 32,000 |
Reported balance
After 2016-10-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-10-24 · Grant · Acquired 32,000 · Balance 32,000 F1: The options vest and become exercisable in equal installments on the first and second anniversary of the date of grant, subject to forfeiture upon termination of employment. |
| Options to purchase common stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.86 · Expires 2026-10-24 | Direct | 13,441 |
Reported balance
After 2016-10-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-10-24 · Grant · Acquired 13,441 · Balance 13,441 F2: The options vest and become exercisable on the first anniversary of the date of the grant, subject to forfeiture upon termination of employment. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest and become exercisable in equal installments on the first and second anniversary of the date of grant, subject to forfeiture upon termination of employment.
F2: The options vest and become exercisable on the first anniversary of the date of the grant, subject to forfeiture upon termination of employment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 24, 2016 Filed Oct 26, 2016 16:13 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 13,441 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001615774-16-007764 · s104433_form4.xml · derivative · entry 2 GAGO AGUSTIN V · CIK 0001235636 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,441 Underlying: Common Stock · 13,441 shares Expires 2026-10-24 F2 · derivative.exercise_date: The options vest and become exercisable on the first anniversary of the date of the grant, subject to forfeiture upon termination of employment. Read SEC document |
| October 24, 2016 Filed Oct 26, 2016 16:13 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 32,000 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001615774-16-007764 · s104433_form4.xml · derivative · entry 1 GAGO AGUSTIN V · CIK 0001235636 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2026-10-24 F1 · derivative.exercise_date: The options vest and become exercisable in equal installments on the first and second anniversary of the date of grant, subject to forfeiture upon termination of employment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.